Related Experiment Video
Updated: Aug 10, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Soluble and membrane-anchored forms of the human IFN-alpha/beta receptor
1Department of Molecular Genetics and Virology, Weizmann Institute of Science, Rehovot, Israel.
Insights
The type I interferon-alpha/beta receptor (IFN-alpha/beta R) and its soluble p40 component were characterized. This research reveals IFN-alpha/beta R
Area of Science:
- Immunology and Virology
- Molecular and Cellular Biology
Background:
- The type I interferon-alpha/beta receptor (IFN-alpha/beta R) is crucial for antiviral responses.
- Understanding the structure and function of IFN-alpha/beta R is essential for developing antiviral therapies.
Purpose of the Study:
- To characterize the ligand-binding component of the type I human IFN-alpha/beta R and its soluble analogue, p40.
- To investigate the role of IFN-alpha/beta R in signal transduction.
Main Methods:
- Cloning and sequencing of cDNA encoding IFN-alpha/beta R and p40.
- Characterization of cellular forms of IFN-alpha/beta R using immunoprecipitation with anti-p40 antibodies.
- Analysis of tyrosine phosphorylation and association with JAK1 kinase upon ligand binding.
Main Results:
- p40 was identified as a potent inhibitor of type I IFNs, and antibodies against p40 blocked IFN activity.
- Cellular IFN-alpha/beta R exists in 102-kDa (major) and 51-kDa (minor) forms.
- A 1.5-kb cDNA codes for the transmembrane 51-kDa IFN-alpha/beta R, and a 4.5-kb cDNA codes for p40.
- IFN-alpha/beta R undergoes tyrosine phosphorylation upon ligand binding and associates with JAK1.
Conclusions:
- The soluble p40 component is critical for type I interferon activity and represents the ligand-binding domain of IFN-alpha/beta R.
- IFN-alpha/beta R is directly involved in signal transduction, interacting with the JAK1 tyrosine kinase.
Abstract:
The recently cloned ligand binding component of the type I human interferon-alpha/beta receptor (IFN-alpha/beta R) and its soluble analogue (p40) were characterized. p40 is a potent inhibitor of type I IFNs and antibodies directed against p40 completely block the activity of type I IFNs in human cells. These antibodies immunoprecipitate cellular 102-kDa (major) and 51-kDa (minor) forms of IFN-alpha/beta R. We find that the 51-kDa IFN-alpha/beta R. Two types of cDNA clones were isolated and sequenced, a 1.5-kb cDNA coding for the transmembrane 51-kDa IFN-alpha/beta R and a 4.5-kb cDNA coding for p40. In addition to ligand binding, IFN-alpha/beta R is directly involved in signaling, because it becomes phosphorylated at Tyr residues on ligand binding and it is physically associated with the cytoplasmic tyrosine kinase JAK1.
More Related Videos
Related Concept Videos
Internal Receptors
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Activation and Inactivation of G Proteins
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...

